Skip to content
Forty51 Ventures logo
Venture Capital

Updated:

Forty51 Ventures

FORTY51 Ventures is a biotech venture creator and company builder. It invests in European early-stage biotech opportunities with a clear path to the clinic,...

Overview

FORTY51 Ventures is a biotech venture creator and company builder. It invests in European early-stage biotech opportunities with a clear path to the clinic, whether single-asset or platform, and acts as the first institutional investor. Founded as a company builder and early-stage investor of exceptional biotech companies in Europe with first or best-in-class potential, it sources and incubates locally and matures companies globally.

General information

Firm type

Venture Capital

Year founded

2022

Location

Region

Europe

Country

Switzerland

City

Basel

Corporate office

Basel, Switzerland

Principals

Sascha Oliver Bucher

Founder

Sara Núñez-García

Founder

Tamás Schweighoffer

Founder

Sector focus

BiotechPharma

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Venture Capital profiles